EPIRUS Biopharmaceuticals Price History

EPRSQDelisted Stock  USD 0.0001  0.00  0.00%   
If you're considering investing in EPIRUS Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of EPIRUS Biopharmaceutica stands at 0.0001, as last reported on the 23rd of April, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for EPIRUS Biopharmaceuticals, which you can use to evaluate the volatility of the firm.
  
EPIRUS Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
EPRSQ
Based on monthly moving average EPIRUS Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EPIRUS Biopharmaceutica by adding EPIRUS Biopharmaceutica to a well-diversified portfolio.

EPIRUS Biopharmaceutica Pink Sheet Price History Chart

There are several ways to analyze EPIRUS Stock price data. The simplest method is using a basic EPIRUS candlestick price chart, which shows EPIRUS Biopharmaceutica price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

EPIRUS Pink Sheet Price History Data

The price series of EPIRUS Biopharmaceutica for the period between Wed, Jan 24, 2024 and Tue, Apr 23, 2024 has a statistical range of 0.0 with a coefficient of variation of 0.0. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.0. The median price for the last 90 days is 0.0. The company completed 1:10 stock split on 16th of July 2014.
OpenHighLowCloseVolume
04/23/2024
 0.0001  0.0001  0.0001  0.0001 
02/07/2023 0.0001  0.0001  0.0001  0.0001  1.00 
02/06/2023 0.0001  0.0001  0.0001  0.0001  1.00 
02/03/2023 0.0001  0.0001  0.0001  0.0001  1.00 
02/02/2023 0.0001  0.0001  0.0001  0.0001  1.00 
02/01/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/31/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/30/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/27/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/26/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/25/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/24/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/23/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/20/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/19/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/18/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/17/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/13/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/12/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/11/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/10/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/09/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/06/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/05/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/04/2023 0.0001  0.0001  0.0001  0.0001  1.00 
01/03/2023 0.0001  0.0001  0.0001  0.0001  1.00 
12/30/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/29/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/28/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/27/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/23/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/22/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/21/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/20/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/19/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/16/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/15/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/14/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/13/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/12/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/09/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/08/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/07/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/06/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/05/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/02/2022 0.0001  0.0001  0.0001  0.0001  1.00 
12/01/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/30/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/29/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/28/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/25/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/23/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/22/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/21/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/18/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/17/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/16/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/15/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/14/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/11/2022 0.0001  0.0001  0.0001  0.0001  1.00 
11/10/2022 0.0001  0.0001  0.0001  0.0001  1.00 

About EPIRUS Biopharmaceutica Pink Sheet history

EPIRUS Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for EPIRUS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in EPIRUS Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing EPIRUS Biopharmaceutica stock prices may prove useful in developing a viable investing in EPIRUS Biopharmaceutica
EPIRUS Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and commercializes biosimilar therapeutics worldwide. On July 25, 2016, Epirus Biopharmaceuticals, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Massachusetts. EPIRUS BIOPHARMACEUTICA operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 73 people.

EPIRUS Biopharmaceutica Pink Sheet Technical Analysis

EPIRUS Biopharmaceutica technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of EPIRUS Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of EPIRUS Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Dashboard Now

   

Portfolio Dashboard

Portfolio dashboard that provides centralized access to all your investments
All  Next Launch Module
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in EPIRUS Pink Sheet

If you are still planning to invest in EPIRUS Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EPIRUS Biopharmaceutica's history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments